HOLOGIC INC Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-07: Reporting owner Valenti Peter J. III; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-07: Reporting owner Oberton Karleen Marie; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-07: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-05: Reporting owner Valenti Peter J. III; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-07 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,908 0 owned after | no price filed | 2018-11-09 | |
| 2018-11-07 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,860 0 owned after | no price filed | 2018-11-09 | |
| 2018-11-07 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,348 0 owned after | no price filed | 2018-11-09 | |
| 2018-11-05 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,086 0 owned after | no price filed | 2018-11-07 | |
| 2018-11-05 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −775 0 owned after | no price filed | 2018-11-07 | |
| 2018-11-05 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,086 0 owned after | no price filed | 2018-11-07 | |
| 2018-11-05 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,119 0 owned after | no price filed | 2018-11-07 | |
| 2018-11-05 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,503 0 owned after | no price filed | 2018-11-07 | |
| 2018-10-03 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,064 0 owned after | no price filed | 2018-11-07 | |
| 2018-05-26 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,347 0 owned after | no price filed | 2018-05-30 | |
| 2018-05-25 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,411 0 owned after | no price filed | 2018-05-30 | |
| 2018-05-25 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −525 0 owned after | no price filed | 2018-05-30 | |
| 2018-03-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −732 712 owned after | no price filed | 2018-03-09 | |
| 2018-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,033 1,033 owned after | no price filed | 2018-02-05 | |
| 2018-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,343 1,343 owned after | no price filed | 2018-02-05 |